Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation-Reference-Cited by-同舟云学术

Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation

Published:2024-01 Issue: Volume:117 Page:102822
ISSN:0143-4160
Container-title:Cell Calcium
language:en
Short-container-title:Cell Calcium

Author:

Guo Guangli,Wang Lu,Li Xiaowei,Fu Wanrong,Cao Jinhua,Zhang Jianchao,Liu Yangyang,Liu Mengduan,Wang Mengyu,Zhao Guojun,Zhao Xi,Zhou Yangfan,Niu Shaohui,Liu Gangqiong,Zhang Yanzhou,Dong Jianzeng,Tao Hailong,Zhao Xiaoyan

Funder

National Natural Science Foundation of China

Postdoctoral Research Foundation of China

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference47 articles.

1. Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: towards the HCM heart team;Pelliccia;Int. J. Cardiol.,2020

2. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines;Ommen;J. Am. Coll. Cardiol.,2020

3. Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC State-of-the-art review;Maron;J. Am. Coll. Cardiol.,2022

4. Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: twenty years with the implantable cardioverter-defibrillator;Maron;Heart Rhythm.,2021

5. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals;Sedaghat-Hamedani;Clin. Res. Cardiol.,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells;International Journal of Molecular Sciences;2024-08-09

2. Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation;Human Cell;2024-05-18